Are you a journalist? Please sign up here for our press releases
Subscribe to our monthly newsletter:
FDA approves third-generation hepatitis B vaccine based on Weizmann research
Dr. Ron Diskin of the Weizmann Institute's Structural Biology Department is concentrating his efforts on a two-pronged research...
Scientists in Israel and Germany show, on the molecular level, how an experimental vaccine offers long-term protection against the disease
Bio-Hep-B, a vaccine for hepatitis B based on Prof. Shaul's research, is produced by Biotechnology General and marketed in Israel
Institute scientists show precisely how a diabetes vaccine works
A team of researchers led by Prof. Irun Cohen of the Weizmann Institute of Science Immunology Department has revealed the...
The uncannily devious flu virus, it turns out, has an Achilles’ heel